Eli Lilly Corp. buy Wolfe Research
Start price
03.12.25
/
50%
€890.10
Target price
03.12.26
€1,074.1
Performance (%)
-13.08%
Price
30.03.26
€773.70
Summary
This prediction is currently active. The price of Eli Lilly Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.08%. This prediction currently runs until 03.12.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -1.326% | -1.326% |
| iShares Core DAX® | -1,66 % | -10,87 % |
| iShares Nasdaq 100 | -3,77 % | -5,15 % |
| iShares Nikkei 225® | -2,80 % | -11,30 % |
| iShares S&P 500 | -2,30 % | -4,80 % |
Comments by Wolfe_Research for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at Wolfe Research from $1,050.00 to $1,250.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Wolfe_Research for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€732.30
15.11.24
15.11.24
€946.80
15.11.25
15.11.25
20.70%
16.11.25
16.11.25
